Journal of Antimicrobial Chemotherapy (2002) 50, 11-18
© 2002 The British Society for Antimicrobial Chemotherapy
Identification of PSE and OXA ß-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism
Department of Microbiology, Hospital Beaujon, 100 boulevard du Général Leclerc, 92110 Clichy, France
Received 3 September 2001; returned 17 January 2002; revised 6 February 2002; accepted 27 March 2002
Objective: A method using PCRrestriction fragment length polymorphism was developed to identify Pseudomonas aeruginosa ß-lactamase genes.
Methods: Two hundred and fifty-nine P. aeruginosa isolates were screened by PCR with 11 primer pairs designed to detect genes encoding PSE, OXA, TEM and SHV enzymes. PSE and OXA gene variants were distinguished by restriction of PCR products with endonucleases recognizing sites involved in point mutations. Nucleotide sequences were verified for a few isolates by sequencing the PCR products.
Results: Four isolates produced extended-spectrum ß-lactamases (ESBLs) according to the double disc synergy test. PCR detecting blaPSE genes was positive in 162 (62.5%) isolates: 151 carried blaPSE-1 and 11 carried a variant encoding an enzyme differing from PSE-1 by a single amino acid substitution (Pro102 to Ser). PCR detecting sequences for enzymes of the OXA-10 group was positive in 68 (26.3%) isolates: 31 carried blaOXA-10, one carried blaOXA-14 and 36 carried a new variant intermediate between blaOXA-13 and blaOXA-19. The blaOXA-2 gene was identified in 13 (5%) isolates. Two other isolates carried blaOXA-2 variants encoding ESBLs differing from OXA-2 by a single amino acid substitution (Asp150 to Tyr and Trp159 to Cys, respectively). PCR detecting sequences for enzymes of the OXA-1 group was positive in 12 (4.6%) isolates. A blaTEM gene was identified in five (1.9%) isolates (three blaTEM-1, one blaTEM-2, one blaTEM-4).
Conclusion: This approach is effective for screening P. aeruginosa for ß-lactamase gene carriage in epidemiological studies and for detecting new variants.
* Corresponding author. Tel: +33-1-40-87-54-42; Fax: +33-1-40-87-05-50; E-mail: bertfrederic{at}hotmail.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. E. Sidjabat, D. L. Paterson, J. M. Adams-Haduch, L. Ewan, A. W. Pasculle, C. A. Muto, G.-B. Tian, and Y. Doi Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4733 - 4739. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Lister, D. J. Wolter, and N. D. Hanson Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms Clin. Microbiol. Rev., October 1, 2009; 22(4): 582 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Strateva and D. Yordanov Pseudomonas aeruginosa - a phenomenon of bacterial resistance J. Med. Microbiol., September 1, 2009; 58(9): 1133 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cui, J. Li, Z. Sun, C. Hu, S. Jin, F. Li, Y. Guo, L. Ran, and Y. Ma Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China J. Antimicrob. Chemother., January 1, 2009; 63(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dubois, C. Arpin, V. Dupart, A. Scavelli, L. Coulange, C. Andre, I. Fischer, F. Grobost, J.-P. Brochet, I. Lagrange, et al. {beta}-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres) J. Antimicrob. Chemother., August 1, 2008; 62(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kiratisin, A. Apisarnthanarak, C. Laesripa, and P. Saifon Molecular Characterization and Epidemiology of Extended-Spectrum- {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2818 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhattacharjee, M. R. Sen, P. Prakash, and S. Anupurba Role of {beta}-lactamase inhibitors in enterobacterial isolates producing extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., February 1, 2008; 61(2): 309 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hocquet, P. Berthelot, M. Roussel-Delvallez, R. Favre, K. Jeannot, O. Bajolet, N. Marty, F. Grattard, P. Mariani-Kurkdjian, E. Bingen, et al. Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3531 - 3536. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhattacharjee, M. R. Sen, S. Anupurba, P. Prakash, and G. Nath Detection of OXA-2 group extended-spectrum-{beta}-lactamase-producing clinical isolates of Escherichia coli from India J. Antimicrob. Chemother., September 1, 2007; 60(3): 703 - 704. [Full Text] [PDF] |
||||
![]() |
T. Strateva, V. Ouzounova-Raykova, B. Markova, A. Todorova, Y. Marteva-Proevska, and I. Mitov Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms J. Med. Microbiol., July 1, 2007; 56(7): 956 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Machado, T. M. Coque, R. Canton, F. Baquero, J. C. Sousa, L. Peixe, and The Portuguese Resistance Study Group Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-Producing Enterobacteriaceae Strains Containing the aac(6')-Ib-cr Gene, Which Encodes an Aminoglycoside- and Fluoroquinolone-Modifying Enzyme. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3220 - 3221. [Full Text] [PDF] |
||||
![]() |
P. Antunes, J. Machado, and L. Peixe Characterization of antimicrobial resistance and class 1 and 2 integrons in Salmonella enterica isolates from different sources in Portugal J. Antimicrob. Chemother., August 1, 2006; 58(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schneider, A. M. Queenan, and A. Bauernfeind Novel Carbapenem-Hydrolyzing Oxacillinase OXA-62 from Pandoraea pnomenusa. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1330 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, Y.-J. Park, M. Kim, H. K. Lee, K. Han, C. S. Kang, and M. W. Kang Prevalence of Ambler class A and D {beta}-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea J. Antimicrob. Chemother., July 1, 2005; 56(1): 122 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Henrichfreise, I. Wiegand, K. J. Sherwood, and B. Wiedemann Detection of VIM-2 Metallo-{beta}-Lactamase in Pseudomonas aeruginosa from Germany Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1668 - 1669. [Full Text] [PDF] |
||||
![]() |
S. Quinteira, J. C. Sousa, and L. Peixe Characterization of In100, a New Integron Carrying a Metallo-{beta}-Lactamase and a Carbenicillinase, from Pseudomonas aeruginosa Antimicrob. Agents Chemother., January 1, 2005; 49(1): 451 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pasteran, D. Faccone, A. Petroni, M. Rapoport, M. Galas, M. Vazquez, and A. Procopio Novel Variant (blaVIM-11) of the Metallo-{beta}-Lactamase blaVIM Family in a GES-1 Extended-Spectrum-{beta}-Lactamase-Producing Pseudomonas aeruginosa Clinical Isolate in Argentina Antimicrob. Agents Chemother., January 1, 2005; 49(1): 474 - 475. [Full Text] [PDF] |
||||
![]() |
Y.-R. Kim, S.-I. Kim, J.-Y. Lee, Y.-J. Park, K.-Y. Lee, and M.-W. Kang NosocomialTransmission of CTX-M-15 and OXA-30 {beta}-Lactamase-Producing Escherichia coli in a Neurosurgical Intensive Care Unit Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 297 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Antunes, J. Machado, J. C. Sousa, and L. Peixe Dissemination amongst humans and food products of animal origin of a Salmonella typhimurium clone expressing an integron-borne OXA-30 {beta}-lactamase J. Antimicrob. Chemother., August 1, 2004; 54(2): 429 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Weldhagen, L. Poirel, and P. Nordmann Ambler Class A Extended-Spectrum {beta}-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2385 - 2392. [Full Text] [PDF] |
||||
![]() |
F. Bert, Z. Ould-Hocine, M. Juvin, V. Dubois, V. Loncle-Provot, V. Lefranc, C. Quentin, N. Lambert, and G. Arlet Evaluation of the Osiris Expert System for Identification of {beta}-Lactam Phenotypes in Isolates of Pseudomonas aeruginosa J. Clin. Microbiol., August 1, 2003; 41(8): 3712 - 3718. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hocquet, X. Bertrand, T. Kohler, D. Talon, and P. Plesiat Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1887 - 1894. [Abstract] [Full Text] [PDF] |
||||





